Cited by 1,192Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Friberg, Leif, Rosenqvist, Mårten, Lip, Gregory Y.H.·2012·European Heart Journal

DOI 10.1093/eurheartj/ehr488

Open this paper in CoChat — free account

Abstract

Aims The impact of some risk factors for stroke and bleeding, and the value of stroke and bleeding risk scores, in atrial fibrillation (AF), has been debated, as clinical trial cohorts have not adequately tested these. Our objective was to investigate risk factors for stroke and bleeding in AF, and application of the new CHA(2)DS(2)-VASc and HAS-BLED schemes for stroke and bleeding risk assessments, respectively. Methods and results We used the Swedish Atrial Fibrillation cohort study, a nationwide cohort study of 182 678 subjects with a diagnosis of AF at any Swedish hospital between 1 July 2005 and 31 December 2008, who were prospectively followed for an average of 1.5 years (260 000 years at risk). With the use of the National Swedish Drug Registry, all patients who used an oral anticoagulant anytime during follow-up were identified. Most of the analyses were made on a subset of 90 490 patients who never used anticoagulants. Risk factors for stroke, the composite thromboembolism endpoint (stroke, TIA, or systemic embolism), and bleeding, and the performance of published stroke and bleeding risk stratification schemes were investigated. On multivariable analysis, significant associations were found between the following 'new' risk factors and thromboembolic events; peripheral artery disease [hazard ratio (HR) 1.22 (95% CI 1.12-1.32)], 'vascular disease' [HR 1.14 (1.06-1.23)], prior myocardial infarction [HR 1.09 (1.03-1.15)], and female gender [HR 1.17 (1.11-1.22)]. Previou…

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehr488

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citation
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,954
Self-citation
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517
Self-citation
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina, R. B. D'Agostino Sr, R. B. D'Agostino Jr, R. S. Vasan, Statistics in Medicine (DOI: 10.1002/sim.2929)
Greenland, P. (2007) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.024 · Cited by 1,077
Self-citation

Show all 48 references

Research works printed but not linked: 2

Atrial Fibrillation Investigators, 1994, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomised clinical trials, Arch Intern Med, 154, 1949
National Collaborating Centre for Chronic Conditions, 2006, Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care

Sorted by citations

Items 401–500 of 999

Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk
Brockmeyer, M., Wolff, G., Krieger, T., Lin, Y., Karathanos, A., Afzal, S., Zeus, T., Westenfeld, R., Polzin, A., Heinen, Y., et al. (2019) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2019.1585643 · Cited by 21
The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study
Tarantini, G., D’Amico, G., Schmidt, B., Mazzone, P., Berti, S. L., Fischer, S., Lund, J., Montorfano, M., Bella, P. E. D., Lam, S. C. C., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.06.003 · Cited by 20
Protocol, rationale and design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): a randomised, open-label study
Zhou, M., Chan, E. W., Hai, J. J., Wong, C., Lau, Y. M., Huang, D., Lam, C. C. S., Tam, C. C., Wong, Y. T. A., Yung, S. Y. A., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038194 · Cited by 21
Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry
Ogawa, H., An, Y., Ishigami, K., Ikeda, S., Doi, K., Hamatani, Y., Fujino, A., Ishii, M., Iguchi, M., Masunaga, N., et al. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa082 · Cited by 20
Self-citation
EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION
Sp, G., Панченко, Е. П., Станиславовна, К. Е., Laiovich, L. I., Maykov, E. B., Mironov, N. Y., & Shakhmatova, O. O. (2019) · Eurasian heart journal · doi:10.38109/2225-1685-2019-4-4-85 · Cited by 21
Stroke in Patients with Atrial Fibrillation: Epidemiology, Screening, and Prognosis
Suomalainen, O., Martinez‐Majander, N., Broman, J., Mannismäki, L., Aro, A. L., Curtze, S., Pakarinen, S., Lehto, M., & Putaala, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010030 · Cited by 21
2023 Guideline for the management of hypertension in the elderly population in China
Hua, Q., Fan, L., Wang, Z., & Li, J. (2024) · 老年心脏病学杂志：英文版 · doi:10.26599/1671-5411.2024.06.001 · Cited by 21
Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age
Eckman, M. H., Lip, G. Y. H., Wise, R. E., Speer, B. B., Sullivan, M., Walker, N., D, B. M. K. M., Flaherty, M. L., Kleindorfer, D., Baker, P., et al. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14099 · Cited by 19
Self-citation
Derivation and Validation of an HIV Risk Prediction Score Among Gay, Bisexual, and Other Men Who Have Sex With Men to Inform PrEP Initiation in an STD Clinic Setting
Tordoff, D. M., Barbee, L. A., Khosropour, C. M., Hughes, J. P., & Golden, M. R. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002438 · Cited by 19
Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure
Pracoń, R., Zieliński, K., Bangalore, S., Konka, M., Kruk, M. B. P., Kępka, C., Trochimiuk, P., Dębski, M. A., Przyłuski, J., Kaczmarska, E., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.02.030 · Cited by 19
Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation
Leiva, O., Jenkins, A., Rosovsky, R. P. G., Leaf, R. K., Goodarzi, K., & Hobbs, G. S. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.10.007 · Cited by 18
CHA 2 DS 2 -VASc Recalibration With an Additional Age Category (50-64 Years) Enhances Stroke Risk Stratification in Chinese Patients With Atrial Fibrillation
Chan, P., Lau, C., Tse, H., Chiang, C., & Siu, C. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.05.009 · Cited by 19
Prognostic Value of Subclinical Coronary Artery Disease in Atrial Fibrillation Patients Identified by Coronary Computed Tomography Angiography
Nous, F. M. A., Budde, R. P. J., van Dijkman, E. D., Musters, P., Nieman, K., & Galema, T. W. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.03.050 · Cited by 19
Outcome and safety of intracardiac echocardiography guided left atrial appendage closure within zero‐fluoroscopy atrial fibrillation ablation procedures
Chen, Y., Wang, L., Zhou, X., Fang, Y., Su, L., Wu, S., Huang, W., & Xiao, F. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15370 · Cited by 19
Transient Ischemic Attacks
Duca, A., & Jagoda, A. S. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.06.007 · Cited by 20
Mechanisms and Prediction of Ischemic Stroke in Atrial Fibrillation Patients
Aarnink, E. W., Zabern, M., Boersma, L. V. A., & Glikson, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206491 · Cited by 20
Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective randomized CLOSURE-AF trial
Landmesser, U., Skurk, C., Kirchhof, P. F., Lewalter, T., Hartung, J., Rroku, A., Pieske, B. M., Brachmann, J., Akın, İ., Jacobshagen, C., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.09.005 · Cited by 19
Atrial Fibrillation Patients Categorized as “Not for Anticoagulation” According to the 2014 Canadian Cardiovascular Society Algorithm Are Not “Low Risk”
Lip, G. Y. H., Nielsen, P. B., Skjøth, F., Rasmussen, L. H., & Larsen, T. B. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.10.018 · Cited by 18
Self-citation
Anticoagulation for Atrial Fibrillation in Patients with Cerebral Microbleeds
Wilson, D., Jäger, H. R., & Werring, D. J. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0524-7 · Cited by 20
Clinical follow-up of left atrial appendage occlusion in patients with atrial fibrillation ineligible of oral anticoagulation treatment—a systematic review and meta-analysis
Labori, F., Bonander, C., Persson, J., & Svensson, M. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-021-00953-9 · Cited by 20
Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real‐world vs. clinical‐trial evidence
Ding, W. Y., Rivera‐Caravaca, J. M., Marín, F. R., Li, G., Roldán, V., & Lip, G. Y. H. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14961 · Cited by 18
Self-citation
Warfarin Treatment and Outcomes of Patients With Atrial Fibrillation in Rural and Urban Settings
Tsadok, M. A., Jackevicius, C. A., Essebag, V., Eisenberg, M. J., Rahme, E., & Pilote, L. (2015) · The Journal of Rural Health · doi:10.1111/jrh.12110 · Cited by 18
Anticoagulation in “real world” patients with atrial fibrillation in Italy: Results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study
Volterrani, M., Iellamo, F., Rosano, G. M. C., Guarini, P., Pusineri, E., Bonassi, S., Chimini, C., Zaccà, F., & Proto, C. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.169 · Cited by 18
Risk stratification using the CHA2DS2-VASc score in patients with coronary heart disease undergoing percutaneous coronary intervention; sub-analysis of SHINANO registry
Hioki, H., Miura, T., Miyashita, Y., Motoki, H., Shimada, K., Kobayashi, M., Nakajima, H., Kimura, H., Mawatari, E., Akanuma, H., et al. (2015) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2015.02.007 · Cited by 18
Antikoagulation bei Patienten mit chronischer Niereninsuffizienz
Schlieper, G., Schwenger, V., Remppis, A., Keller, T., Dechend, R., Maßberg, S., Baldus, S. E., Weinreich, T., Hetzel, G. R., Floege, J., et al. (2017) · Der Internist · doi:10.1007/s00108-017-0220-5 · Cited by 19
Factors Associated with Anticoagulation Delay Following New-Onset Atrial Fibrillation
Khurshid, S. S., Weng, L.-C. C., Hulme, O. L., Ellinor, P. T., & Lubitz, S. A. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.017 · Cited by 18
Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
Sabbag, A., Yao, X., Siontis, K. C., & Noseworthy, P. A. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0261 · Cited by 19
Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: A multicenter registry.
Krittayaphong, R., Phrommintikul, A., Ngamjanyaporn, P., Siriwattana, K., Kanjanarutjawiwat, W., Chantrarat, T., Rojjarekampai, R., Kaewcomdee, P., & Sonkhammee, P. (2019) · PubMed Central · doi:10.11909/j.issn.1671-5411.2019.03.004 · Cited by 18
Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
Perreault, S., Côté, R., White‐Guay, B., Dorais, M., Oussaïd, E., & Schnitzer, M. E. (2019) · Journal of Stroke · doi:10.5853/jos.2018.02243 · Cited by 18
Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure
Pouru, J.-P., Jaakkola, S., Lund, J., Biancari, F., Saraste, A., & Airaksinen, J. K. E. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.08.050 · Cited by 18
Thromboelastometry for Assessing Risks of Free Flap Thrombosis in Patients Undergoing Microvascular Surgery
Vanags, I., Stepanovs, J., Ozoliņa, A., Mukāns, M., Bjertnæs, L. J., & Mamaja, B. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00289 · Cited by 18
Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study
Kim, K., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Sung, J., Pak, H., Lee, M., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.08.018 · Cited by 18
Self-citation
Potential use of NOACs in developing countries: pros and cons
Bista, D., Chalmers, L., Bereznicki, L., & Peterson, G. M. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1693-y · Cited by 18
Comparison of Anticoagulant Therapy for Atrial Fibrillation - Novel Oral Anticoagulants Versus Vitamin K Antagonists
Chen, S. T., & Patel, M. R. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.01.005 · Cited by 20
Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease.
Khouri, Y. S., Stephens, T., Ayuba, G. A., Al‐Ameri, H., Juratli, N., & McCullough, P. A. (2015) · Europe PMC (PubMed Central) · doi:10.4022/jafib.1069 · Cited by 18
Long‐term risk of stroke and bleeding post–atrial fibrillation ablation
Joza, J. E., Samuel, M., Jackevicius, C. A., Behlouli, H., Jia, J., Koh, M., Tsadok, M. A., TANG, A. S. L., Verma, A., Pilote, L., et al. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13702 · Cited by 17
Percutaneous left atrial appendage closure in patients with prior intracranial bleeding and thromboembolism
Pouru, J.-P., Lund, J., Jaakkola, S., Vasankari, T., Biancari, F., Saraste, A., & Airaksinen, J. K. E. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.01.028 · Cited by 17
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy”
Huijboom, M., Maarse, M., Aarnink, E. W., van Dijk, V. F., Swaans, M. J., van der Heijden, J. F., Ijsselmuiden, S., Folkeringa, R., Blaauw, Y., Elvan, A., et al. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.05.001 · Cited by 17
Predictive value of neutrophil to lymphocyte ratio for ischemic stroke in patients with atrial fibrillation: A meta-analysis
Lu, M., Zhang, Y., Liu, R., He, X., & Hou, B.-N. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1029010 · Cited by 17
Left atrial appendage occlusion after thromboembolic events or left atrial appendage sludge during anticoagulation therapy: Is two better than one? Real‐world experience from a tertiary care hospital
Margonato, D., Preda, A., Ingallina, G., Rizza, V., Fierro, N., Radinovic, A., Ancona, F., Patti, G., Agricola, E., Bella, P. E. D., et al. (2023) · Journal of Arrhythmia · doi:10.1002/joa3.12838 · Cited by 17
Validation of CHA2DS2 VASc Score Predictability of Stroke and Systemic Embolization in a Middle Eastern Population with AF: The Jordan Atrial Fibrillation (JoFib) Study
Ibdah, R., Obeidat, O., Khader, Y. S., Al‐Nusair, J., Abusurrah, O., Obeidat, A., Obeidat, A. M., Rawashdeh, S., Alrabadi, N., Obiedat, A. F., et al. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s404575 · Cited by 17
Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives
Durrant, J., Lip, G. Y. H., & Lane, D. A. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.161 · Cited by 17
Self-citation
Initiation of rivaroxaban in patients with nonvalvular atrial fibrillation at the primary care level:
Engelberger, R. P., Noll, G., Schmidt, D., Alatri, A., Frei, B., Kaiser, W. E., & Kucher, N. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.04.014 · Cited by 17
Treatment of Intracerebral Hemorrhage Associated with New Oral Anticoagulant Use
Veltkamp, R. C., & Horstmann, S. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.06.007 · Cited by 17
Anticoagulation in Older Adults with Multimorbidity
Parks, A. L., & Fang, M. C. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.01.003 · Cited by 18
Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus.
Peacock, W., Tamayo, S. G., Sicignano, N., Hopf, K., Yuan, Z., & Patel, M. (2017) · American Journal of Cardiology · doi:10.1016/j.amjcard.2016.11.023 · Cited by 18
Clinical decision support for stroke prevention in atrial fibrillation (CDS-AF): Rationale and design of a cluster randomized trial in the primary care setting
Karlsson, L., Nilsson, S., Charitakis, E., Bång, M., Johansson, G., Nilsson, L. E., & Janzon, M. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.02.009 · Cited by 16
Reducción de eventos a largo plazo tras el cierre de la orejuela izquierda. Resultados del Registro Ibérico II
López-Mínguez, J. R., Nogales‐Asensio, J. M., de Oliveira, E. I., Ribeiro, V. G., Ruiz-Salmeron, R. J., Arzamendi, D., da Costa, M. A. F., Gutiérrez-García, H., Díaz, J. A. F., Martín‐Yuste, V., et al. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.03.020 · Cited by 17
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation
Zhang, L., Yan, X., Fox, K. A. A., Willmann, S., Nandy, P., Berkowitz, S. D., Hermanowski‐Vosatka, A., Weitz, J. I., Solms, A., Schmidt, S., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02077-9 · Cited by 17
Utility of HAS-BLED and CHA2DS2-VASc Scores Among Patients With Atrial Fibrillation and Imaging Evidence of Cerebral Amyloid Angiopathy
Ward, R. C., Ponamgi, S., DeSimone, C. V., English, S. W., Hodge, D. O., Slusser, J. P., Graff‐Radford, J., Rabinstein, A. A., Asirvatham, S. J., & Holmes, D. R. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.03.034 · Cited by 17
CHADS2, CHA2DS2-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation
Yu, I., Song, T., Kim, B. J., Heo, S. H., Jung, J., Oh, K., Kim, C. K., Yu, S., Park, K., Kim, J., et al. (2021) · Medicine · doi:10.1097/md.0000000000024000 · Cited by 17
The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
Reardon, B., Pasalic, L., & Favaloro, E. J. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8090115 · Cited by 17
Perioperative Anticoagulation Management
Briete, L. D., Towers, W. F., Bone, R., Nair, R., Steck, M., Cutshall, B. T., & Shah, S. P. (2022) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000395 · Cited by 17
Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks
Esteve‐Pastor, M. A., Rivera‐Caravaca, J. M., & Lip, G. Y. H. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx135 · Cited by 17
Self-citation
External Validation of the HELT-E2S2 Score in Japanese Patients With Nonvalvular Atrial Fibrillation ― A Pooled Analysis of the RAFFINE and SAKURA Registries ―
Yamauchi, T., Okumura, Y., Nagashima, K., Watanabe, R., Saito, Y., Yokoyama, K., Matsumoto, N., Miyauchi, K., Miyazaki, S., Hayashi, H., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-23-0318 · Cited by 16
Value of Intraplaque Neovascularization on Contrast-Enhanced Ultrasonography in Predicting Ischemic Stroke Recurrence in Patients With Carotid Atherosclerotic Plaque
Huang, Z., Cheng, X.-Q., Liu, Y., Bi, X., & Deng, Y. (2023) · Korean Journal of Radiology · doi:10.3348/kjr.2022.0977 · Cited by 16
Reduced Left Atrial Rotational Flow Is Independently Associated With Embolic Brain Infarcts
Spartera, M., Stracquadanio, A., Pessoa-Amorim, G., Harston, G., Mazzucco, S., Young, V. E. L., Ende, A. V., Hess, A. T., Ferreira, V. M., Kennedy, J., et al. (2023) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2023.03.006 · Cited by 16
Performance of Different Risk Scores for the Detection of Atrial Fibrillation Among Patients With Cryptogenic Stroke
Palaiodimou, L., Theodorou, A., Triantafyllou, S., Dilaveris, P., Flevari, P., Γιαννόπουλος, Γ., Kossyvakis, C., Adreanides, E., Tympas, K., Nikolopoulos, P. M., et al. (2024) · Stroke · doi:10.1161/strokeaha.123.044961 · Cited by 16
Left Atrial Appendage Occlusion and Post-procedural Antithrombotic Management
Kramer, A. D., Patti, G., Nielsen‐Kudsk, J. E., Berti, S. L., & Korsholm, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030803 · Cited by 16
Results from the Registry of Atrial Fibrillation (AFABE): Gap between Undiagnosed and Registered Atrial Fibrillation in Adults—Ineffectiveness of Oral Anticoagulation Treatment with VKA
Panisello-Tafalla, A., Clua‐Espuny, J. L., Gil-Guillén, V. F., González-Henares, A., Queralt-Tomas, M. L., López, C., Lucas-Noll, J., Lechuga-Durán, Í., Ripolles-Vicente, R., Carot-Domenech, J., et al. (2015) · BioMed Research International · doi:10.1155/2015/134756 · Cited by 16
Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012
Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., Baumgartner, H., et al. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.11.001 · Cited by 16
Self-citation
Characteristics of patients with non-valvular atrial fibrillation using dabigatran or warfarin in the US
Schoof, N., Schnee, J. M., Schneider, G., Gawlik, M., Zint, K., Clemens, A., & Bartels, D. B. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.879529 · Cited by 16
Emerging Tools for Stroke Prevention in Atrial Fibrillation
Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.017 · Cited by 16
Self-citation
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis
Guerra, F., Scappini, L., Maolo, A., Campo, G. C., Pavasini, R., Shkoza, M., & Capucci, A. (2016) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872616673536 · Cited by 16
Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor
Potpara, T., Dagres, N., Mujović, N. M., Vasić, D., Ašanin, M., Nedeljkovic, M. A., Marín, F. R., Fauchier, L., Blomström‐Lundqvist, C., & Lip, G. Y. H. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0458-7 · Cited by 16
Self-citation
Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami
Cerasuolo, J. O., Montero‐Odasso, M., Ibáñez, A. M., Doocy, S., Lip, G. Y. H., & Sposato, L. A. (2017) · International Journal of Stroke · doi:10.1177/1747493016687579 · Cited by 17
Self-citation
Kommentar zu den 2016 Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zum Management von Vorhofflimmern
Eckardt, L., Deneke, T., Diener, H., Hindricks, G., Hoffmeister, H. M., Hohnloser, S. H., Kirchhof, P. F., & Stellbrink, C. (2017) · Der Kardiologe · doi:10.1007/s12181-017-0141-5 · Cited by 16
Patients with Heart Failure and Preserved Ejection Fraction Are at Risk of Gastrointestinal Bleeding
Schrutka, L., Seirer, B., Duca, F., Binder, C., Dalos, D., Kammerlander, A. A., Aschauer, S., Koller, L., Benazzo, A., Agibetov, A., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081240 · Cited by 16
The History of the Left Atrial Appendage Occlusion
Holmes, D. R., & Alkhouli, M. A. (2020) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2019.11.009 · Cited by 16
Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia
Leader, A., Gurevich‐Shapiro, A., & Spectre, G. (2020) · Thrombosis Research · doi:10.1016/s0049-3848(20)30400-x · Cited by 16
Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge
Qazi, J. Z., Schnitzer, M. E., Côté, R., Martel, M.-J., Dorais, M., & Perreault, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246691 · Cited by 16
Sex Differences in Safety and Effectiveness of LAAO
Alkhouli, M. A., Russo, A. M., Thaler, D. E., Windecker, S., Anderson, J. A., Gage, R., & Lakkireddy, D. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.06.037 · Cited by 16
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
Esteve‐Pastor, M. A., Rivera‐Caravaca, J. M., Roldán, V., Sanmartı́n, M., Arribas, F., Masjuán, J., Barrios, V., Cosı́n-Sales, J., Freixa‐Pamias, R., Recalde, E., et al. (2022) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvac060 · Cited by 16
Self-citation
Atrial fibrillation in outpatients with stable coronary artery disease : results from the multicenter RECENT study
Zielonka, A., Tkaczyszyn, M., Mende, M., Nowak, W., Rekucki, K., Soczomski, P., Zieliński, M., Pociupany, R., Wilkins, A., Banasiak, W., et al. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2709 · Cited by 16
A clinical decision instrument to predict 30-day death and cardiovascular hospitalizations after an emergency department visit for atrial fibrillation: The Atrial Fibrillation in the Emergency Room, Part 2 (AFTER2) study
Atzema, C. L., Dorian, P., Fang, J., Tu, J. V., Lee, D. S., Chong, A. S., & Austin, P. C. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.06.005 · Cited by 16
Atrial Fibrillation and Heart Failure: A Bad Combination
Lau, Y. C., Lane, D. A., & Lip, G. Y. H. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.01.002 · Cited by 16
Self-citation
Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation
Ravvaz, K., Weissert, J. A., Jahangir, A., & Ruff, C. T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248134 · Cited by 15
Long-Term Efficacy and Anticoagulation Strategy of Left Atrial Appendage Occlusion During Total Thoracoscopic Ablation of Atrial Fibrillation to Prevent Ischemic Stroke
Kim, J. Y., Jeong, D. S., Park, S., Park, K., Kim, J. S., & On, Y. K. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.853299 · Cited by 15
Identifying adolescents at risk for depression: Assessment of a global prediction model in the Great Smoky Mountains Study
Caye, A., Marchionatti, L. E., Pereira, R. B., Fisher, H. L., Kohrt, B. A., Mondelli, V., McGinnis, E. W., Copeland, W., & Kieling, C. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.08.017 · Cited by 16
Bleeding risk evaluation in cerebral cavernous malformation, the role of medications, and hemorrhagic factors: a case-control study
Scerrati, A., Mantovani, G., Travaglini, F., Bradaschia, L., BONIS, P. D., Farneti, M., Cavallo, M. A., Dones, F., Flacco, M. E., Auricchio, A., et al. (2023) · Neurosurgical FOCUS · doi:10.3171/2023.7.focus23355 · Cited by 15
Does CHA2DS2-VASc Improve Stroke Risk Stratification in Postmenopausal Women with Atrial Fibrillation?
Abraham, J. M., Larson, J. C., Chung, M. K., Curtis, A. B., Lakshminarayan, K., Newman, J. D., Perez, M. V., Rexrode, K. M., Shara, N. M., Solomon, A. J., et al. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.05.023 · Cited by 15
Outcome of left atrial appendage occlusion in high-risk patients
Masoud, A. T., Bartoletti, S., Fairbairn, T. A., Khurana, A., Velavan, P., Morrison, W. L., Khalatbari, A., Aggarwal, S. K., Sharma, N., Kirchhof, P. F., et al. (2017) · Heart · doi:10.1136/heartjnl-2017-312383 · Cited by 15
Impact of sex differences on outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure: A single-center experience
Zhao, M., Post, F., Muenzel, M., Hou, C. R., Keil, T., & Yu, J. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.53221 · Cited by 15
Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score
Würtz, M., Olesen, K. K. W., Mortensen, M. B., Eikelboom, J. W., Mohammad, M. A., Erlinge, D., Kristensen, S. D., & Mæng, M. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab785 · Cited by 16
Early Discontinuation of Antithrombotic Treatment Following Left Atrial Appendage Closure
Mesnier, J., Cruz‐González, I., Arzamendi, D., Freixa, X., y, L. N.-F., Peral, V., Caneiro‐Queija, B., Mangieri, A., Trejo‐Velasco, B., Asmarats, L., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.01.055 · Cited by 15
Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devices
Ke, J.-Y., Jin, L.-S., Lin, Y.-N., Xu, J., Liu, W.-K., Fu, J.-Y., Li, L., Chen, Y.-L., Qiu, Y.-X., & Li, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1011037 · Cited by 15
Use of Guidelines for Reducing Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: A Review From a Latin American Perspective
Cantú-Brito, C. G., Silva, G. S., & Ameriso, S. F. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029617734309 · Cited by 14
The CHA 2 DS 2 -VASc score: Not as simple as it seems
Jia, X., Levine, G. N., & Birnbaum, Y. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.12.027 · Cited by 15
Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices
Wintgens, L. I. S., Klaver, M. N., Swaans, M. J., Alipour, A., Balt, J. C., van Dijk, V. F., Rensing, B. J. W. M., WIJFFELS, M. C. E. F., & Boersma, L. V. A. (2018) · EP Europace · doi:10.1093/europace/euy237 · Cited by 15
Comparing Management and Outcomes in Men and Women With Nonvalvular Atrial Fibrillation
Arnson, Y., Hoshen, M., Senderey, A. B., Reges, O., Balicer, R. D., Leibowitz, M., Tsadok, M. A., & Haim, M. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.01.014 · Cited by 15
The relationship between incomplete surgical obliteration of the left atrial appendage and thromboembolic events after mitral valve surgery (from the ISOLATE Registry)
Güner, A., Kalçık, M., Gündüz, S., Gürsoy, M. O., Güner, E. G., Ulutaş, A. E., Kalkan, S., Onan, B., Bayam, E. M., Ertük, M., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02291-5 · Cited by 14
Incorporating coronary calcification by computed tomography into CHA2DS2-VASc score: impact on cardiovascular outcomes in patients with atrial fibrillation
Wang, T. K. M., Chan, N., Cremer, P. C., Kanj, M. H., Baranowski, B. J., Saliba, W. I., Wazni, O. M., & Jaber, W. A. (2021) · EP Europace · doi:10.1093/europace/euab032 · Cited by 15
Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?
Rivas, A., Lauw, M. N., Schnabel, R. B., Crowther, M. A., & Spall, H. G. C. V. (2022) · Thrombosis and Haemostasis · doi:10.1055/a-1745-2083 · Cited by 15
Adding Rigor to Stroke Risk Prediction in Atrial Fibrillation
Singer, D. E., & Ezekowitz, M. D. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.013 · Cited by 15
“R” for “Renal” and for “Risk”
Camm, A. J., & Savelieva, I. (2013) · Circulation · doi:10.1161/circulationaha.112.147512 · Cited by 15
Communication Patterns in Consultations Between Patients with Atrial Fibrillation and Health Professionals
Siouta, E. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 15
Left atrial appendage occlusion in patients with end-stage renal disease: an individual patient-level meta-analysis
Rodriguez‐Riascos, J. F., Vemulapalli, H. S., Akın, İ., Areiza, L. A., Rocca, D. G. D., Eitel, I., Fink, T., Genovesi, S., Kefer, J., Zweiker, D., et al. (2025) · EP Europace · doi:10.1093/europace/euaf198 · Cited by 14
Representation of Women in Atrial Fibrillation Clinical Practice Guidelines
Alipour, P., Azizi, Z., Norris, C. M., Raparelli, V., McMurtry, M. S., Macle, L., Andrade, J. G., & Pilote, L. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.12.017 · Cited by 14
Thromboembolic risk and oral anticoagulation in subclinical atrial fibrillation
Wegner, F. K., & Eckardt, L. (2024) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2024.04.001 · Cited by 14
Fibrinaloid Microclots and Atrial Fibrillation
Kell, D. B., Lip, G. Y. H., & Pretorius, E. (2024) · Biomedicines · doi:10.3390/biomedicines12040891 · Cited by 14
Self-citation

Authors: Friberg, L., Rosenqvist, M., & Lip, G. Y. H.
Affiliations: Danderyds sjukhus (SE)
Karolinska Institutet (SE)
Birmingham City Hospital (GB)
Corresponding author: Lip, Gregory Y.H.
ORCID: Friberg, Leif
Lip, Gregory Y.H.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2012-01-13
Volume: 33
Issue: 12
Pages: 1500-1510
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/ehr488
OpenAlex: W2124601103
Cited by: 1,192
References: 48
Citations by year: 2026: 37 · 2025: 60 · 2024: 74 · 2023: 81 · 2022: 112 · 2021: 99 · 2020: 100 · 2019: 99 · 2018: 78 · 2017: 99 · 2016: 75 · 2015: 99 · 2014: 72 · 2013: 68 · 2012: 35
FWCI: 56.38
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders: Stockholms Läns Landsting
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: atrial fibrillation, stroke risk stratification, bleeding risk stratification, CHA2DS2-VASc score, HAS-BLED score, thromboembolism, intracranial hemorrhage, risk factors, peripheral arterial disease, oral anticoagulants, thyroid dysfunction, hyperthyroidism, concordance index
MeSH terms: Adult, Aged, Anticoagulants, Atrial Fibrillation, Female, Hemorrhage, Humans, Male, Middle Aged, Risk Factors, Sweden, Thromboembolism, Cohort Studies, Risk Assessment, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks